• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌的遗传和激素风险因素。

Genetic and hormonal risk factors in breast cancer.

作者信息

Martin A M, Weber B L

机构信息

Department of Medicine, Division of Hematology and Oncology, University of Pennsylvania, Philadelphia 19104, USA.

出版信息

J Natl Cancer Inst. 2000 Jul 19;92(14):1126-35. doi: 10.1093/jnci/92.14.1126.

DOI:10.1093/jnci/92.14.1126
PMID:10904085
Abstract

Breast cancer poses a serious public health problem, and it is hoped that identification of genetic and environmental factors that contribute to the development of breast cancer will enhance prevention efforts. Two breast cancer susceptibility genes (BRCA1 and BRCA2) have been identified, and germline mutations in these genes are thought to account for between 5% and 10% of all breast cancer cases. Current findings suggest that mutations in other highly penetrant genes may play an important role in breast cancer susceptibility, and studies aimed at the isolation of these genes are under way. In addition, common variants in a number of gene classes are thought to act as low-penetrance susceptibility alleles, and efforts to identify and characterize these variants are under way. This review discusses the genetic components of susceptibility to breast cancer from the standpoint of both human genetics and rat models.

摘要

乳腺癌是一个严重的公共卫生问题,人们希望识别出导致乳腺癌发生的遗传和环境因素能够加强预防工作。已发现两种乳腺癌易感基因(BRCA1和BRCA2),这些基因的种系突变被认为占所有乳腺癌病例的5%至10%。目前的研究结果表明,其他高外显率基因的突变可能在乳腺癌易感性中起重要作用,旨在分离这些基因的研究正在进行。此外,一些基因类别的常见变异被认为是低外显率易感等位基因,识别和表征这些变异的工作也正在进行。本文从人类遗传学和大鼠模型的角度讨论了乳腺癌易感性的遗传成分。

相似文献

1
Genetic and hormonal risk factors in breast cancer.乳腺癌的遗传和激素风险因素。
J Natl Cancer Inst. 2000 Jul 19;92(14):1126-35. doi: 10.1093/jnci/92.14.1126.
2
Low penetrance genes associated with increased risk for breast cancer.与乳腺癌风险增加相关的低外显率基因。
Eur J Cancer. 2000 Jun;36(10):1193-9. doi: 10.1016/s0959-8049(00)00082-4.
3
[Research on breast cancer susceptibility genes].[乳腺癌易感基因的研究]
Ai Zheng. 2002 Sep;21(9):1035-9.
4
Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.乳腺癌中芳香族DNA加合物以及CYP1A1、NAT2和GSTM1的多态性
Carcinogenesis. 2002 Feb;23(2):301-6. doi: 10.1093/carcin/23.2.301.
5
"Other" breast cancer susceptibility genes: searching for more holy grail.“其他”乳腺癌易感基因:探寻更多圣杯
Hum Mol Genet. 2001 Apr;10(7):715-20. doi: 10.1093/hmg/10.7.715.
6
A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.捷克遗传性乳腺癌和乳腺-卵巢癌家族中BRCA1和BRCA2突变的高发生率。
Cas Lek Cesk. 2000 Oct 11;139(20):635-7.
7
[The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].[加拿大魁北克奠基人群体法裔加拿大乳腺癌和乳腺-卵巢癌家族中致病性BRCA1和BRCA2突变的有限谱]
Bull Cancer. 2006 Sep;93(9):841-6.
8
Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.一项基于人群的研究中除BRCA1和BRCA2外的其他乳腺癌易感基因的证据。
Genet Epidemiol. 2001 Jul;21(1):1-18. doi: 10.1002/gepi.1014.
9
Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.早发性乳腺癌患者中BRCA1和BRCA2基因突变的患病率。
J Natl Cancer Inst. 1999 Jun 2;91(11):943-9. doi: 10.1093/jnci/91.11.943.
10
Evaluation of genotype data in clinical risk assessment: methods and application to BRCA1, BRCA2, and N-acetyl transferase-2 genotypes in breast cancer.临床风险评估中基因数据的评估:方法及在乳腺癌中BRCA1、BRCA2和N - 乙酰转移酶 - 2基因分型中的应用
Genet Test. 1997;1(3):157-64. doi: 10.1089/gte.1997.1.157.

引用本文的文献

1
Anthropometry and the Risk of Breast Cancer in Moroccan Women: A Large Multicentric Case-Control Study.摩洛哥女性的人体测量学与乳腺癌风险:一项大型多中心病例对照研究
Curr Oncol. 2025 Jul 31;32(8):434. doi: 10.3390/curroncol32080434.
2
Role of Oxidative Stress in the Occurrence, Development, and Treatment of Breast Cancer.氧化应激在乳腺癌发生、发展及治疗中的作用
Antioxidants (Basel). 2025 Jan 17;14(1):104. doi: 10.3390/antiox14010104.
3
PARP Pioneers: Using BRCA1/2 Mutation-targeted Inhibition to Revolutionize Breast Cancer Treatment.
PARP先驱者:利用针对BRCA1/2突变的抑制作用彻底改变乳腺癌治疗方法
Curr Pharm Des. 2025;31(9):663-673. doi: 10.2174/0113816128322894241004051814.
4
ARTEMIS: An independently validated prognostic prediction model of breast cancer incorporating epigenetic biomarkers with main effects and gene-gene interactions.ARTEMIS:一种经过独立验证的乳腺癌预后预测模型,该模型纳入了具有主效应和基因-基因相互作用的表观遗传生物标志物。
J Adv Res. 2025 Jul;73:561-573. doi: 10.1016/j.jare.2024.08.015. Epub 2024 Aug 11.
5
Expression of Intragenic LCAL4 Long Non-Coding RNAs as a Potential Diagnostic and Prognostic Marker in Female Breast Cancer.基因内LCAL4长链非编码RNA在女性乳腺癌中作为潜在诊断和预后标志物的表达
J Family Reprod Health. 2024 Jun;18(2):129-139. doi: 10.18502/jfrh.v18i2.15937.
6
Breast Cancer in a Filipino Male: A Case Report and Brief Literature Review.一名菲律宾男性的乳腺癌:病例报告及文献综述
Acta Med Philipp. 2024 Feb 28;58(3):70-75. doi: 10.47895/amp.vi0.6742. eCollection 2024.
7
Knowledge, awareness and attitude towards breast cancer: Risk factors, signs and screening among Health and Allied students: A prospective study.健康及相关专业学生对乳腺癌的认知、意识和态度:风险因素、体征及筛查的前瞻性研究
J Family Med Prim Care. 2024 May;13(5):1804-1824. doi: 10.4103/jfmpc.jfmpc_1720_23. Epub 2024 May 24.
8
Evaluation of digit ratio (2D:4D) in breast cancer patients.评估乳腺癌患者的 2D:4D 比值。
Sci Rep. 2024 Jun 14;14(1):13722. doi: 10.1038/s41598-024-64692-3.
9
Global untargeted and individual targeted plasma metabolomics of breast cancer recurrence modified by hormone receptors.基于激素受体的乳腺癌复发的全球非靶向和个体靶向血浆代谢组学。
Breast Cancer. 2024 Jul;31(4):659-670. doi: 10.1007/s12282-024-01579-1. Epub 2024 Apr 23.
10
Tissue Expression of Growth Differentiation Factor 11 in Patients with Breast Cancer.生长分化因子11在乳腺癌患者中的组织表达
Diagnostics (Basel). 2024 Mar 27;14(7):701. doi: 10.3390/diagnostics14070701.